BBSRC Portfolio Analyser
Award details
Replication of infectivity in vitro
Reference
BBS/E/I/00000657
Principal Investigator / Supervisor
Dr James Hope
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
116,407
Status
Completed
Type
Institute Project
Start date
02/10/1997
End date
01/10/2000
Duration
36 months
Abstract
On binding to PrPSc in vitro, PrPC becomes more resistant to hydrolysis, epitopes in its 90-120 region are masked and the altered 'PrPC' can be pelleted from solution in association with PrPSc. By these biophysical, biochemical and immunological criteria several which have long been used to define the infectious prion several the PrPC has been converted to PrPSc. If PrPSc is infectious then it should be possible to show the de novo production of infectivity by bioassay. Current failure to show 'new' infectious particles may reflect technical inadequacy or the inadequacy of the prion hypothesis itself. Novel methods of high- efficiency conversion and protein fractionation are in development to underpin future biological assay investigations of this idea.
Summary
unavailable
Committee
Closed Committee - Agri-food (AF)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search